Sentences with phrase «vaccine against cervical cancer»

His discovery led to the development of a vaccine against cervical cancer.

Not exact matches

In the battle against cervical cancer, can fewer injections of the vaccine be just as effective in adolescents?

Democrats and liberal groups have successfully attacked Heck on social security privatization and a vote in the state Senate against a bill that would have required insurance companies to cover a vaccine for cervical cancer.

The HPV vaccine is safe and simple — and stopping HPV infection can help protect against cervical cancer developing.

There are concerns the vaccine, which guards against four types of the HPV shown to cause cervical cancer and anogenital warts, may give girls a false sense of security about contracting sexually transmitted infections (STIs) and lead them to engage in riskier sexual activity.

In addition to protecting against 80 percent of cervical cancers, the new 9 - Valent human papillomavirus vaccine, which includes seven cancer causing HPV - types, has the potential to protect against nearly 19,000 other cancers diagnosed in the United States, including anal, oropharyngeal and penile cancers.

Although Merck's vaccine will be marketed only for cervical cancer, preliminary evidence suggests it may also be effective against penile, anal, and vulvar cancers and even certain cancers of the head and neck.

The only VLP - based vaccine to hit the U.S. market is Merck & Co.'s Gardasil, which won FDA approval in June as preventative against certain types of human papillomavirus (HPV), which could lead to cervical cancer.

Fears that vaccination against the virus that causes cervical cancer might encourage girls to become more sexually active are unfounded, suggests a survey of UK teenagers who have received or been offered the vaccine.

The FDA approved Merck's Gardasil vaccine in 2006, after clinical trials showed that it protects against four strains of human papillomavirus (HPV), which together cause about 70 percent of cervical cancers and 90 percent of genital warts.

Although use of the human papillomavirus (HPV) vaccine, which helps prevent against cervical and other cancers, has increased in the past 5 years, HPV vaccination remains low with only 37.6 % of adolescent girls and 13.9 % of adolescent boys receiving vaccination.

The affordable vaccine will at first protect against just a single strain of HPV that accountsfor 50 percent of cervical cancer.

Despite the widespread use of screening programs and the recent advent of vaccines against human papilloma virus, cervical cancer continues to be a significant public health problem.

Effective preventive vaccines against the most oncogenic forms of HPV have been available for a number of years, with vaccination having the long - term potential to reduce the number of cases of cervical cancer,» said NCI Acting Director Douglas Lowy, M.D.

Last year the FDA approved Gardasil, a vaccine effective against four strains of human papillomavirus (HPV) that cause 90 percent of genital warts and 70 percent of all cases of cervical cancer.

A new study finds that a simple reminder via electronic health record systems may go a long way in encouraging patients to get the HPV vaccine that protects against cervical cancer.

The HPV vaccine, which protects against four types of HPV shown to cause cervical cancer and anogenital warts, is offered free through school - based programs to young girls across Canada.

Advocates of the vaccine point out that the jabs work against human papillomavirus (HPV)-- which causes virtually all cases of cervical cancer — and are safe.

The latest data from a large clinical trial of Merck's cervical cancer vaccine, Gardasil, found it offered 100 % protection against cervical, vulval and vaginal diseases, caused by HPV (types 6, 11, 16 and 18) and 98 % protection against advanced pre-cancers caused by HPV types 16 and 18 (New England Journal of Medicine: vol 356, p1915).

However, the introduction of a vaccine against HPV types 16 and 18, which together cause 70 % of cervical cancer cases, has been dogged by arguments.

The vaccines protect against the sexually transmitted virus that causes cervical cancer, which kills almost a quarter of a million women worldwide each year.

The FDA approves Cervarix, a second vaccine that protects against persistent infection with the two types of HPV that cause approximately 70 percent of all cases of cervical cancer worldwide.

This includes utilizing a modified chimpanzee virus as a vaccine carrier to induce an immune response against HIV, and a new therapeutic vaccine against human papillomavirus (HPV), a leading cause of cervical cancer.

The study relates to a particular type of vaccine (killed) against a particular virus, influenza, though the findings might hold true for other killed vaccines and for those vaccines consisting only of proteins produced by GM in bacteria, yeast or insect cells, against diseases such as hepatitis B (HBV) and human papilloma virus (HPV, the causative agent of cervical cancer).

The vaccine protects against HPV, which can cause cervical cancer, other cancers and genital warts.

THURSDAY, Sept. 29, 2016 (HealthDay News)-- The vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds.

The HPV vaccines don't help treat cervical cancer, but they are all effective in protecting against the two types of HPV that cause about 70 percent of cervical cancers, according to the FDA.

One vaccine — Gardasil 9 — also offers protection against five additional HPV types that cause about 20 percent of cervical cancers.

The researchers say that the efficacy of the vaccine was «high,» but mostly in terms of protecting against infection — not cervical cancer.

The vaccine protects against four types of HPV, including two that cause about 70 % of cervical cancer.

Experts agree that the vaccine does not replace the need for regular Pap smears, since it protects only against the strains of the virus that cause 70 % of all cervical cancers.

Although vaccines against some of the most dangerous HPV strains have been approved for girls ages 13 to 26, the vaccines are expensive and routine Pap tests are still necessary to pick up cervical cancers.

In human medicine, our growing knowledge about the role of viruses as a cause of certain cancers has led to the development of vaccines as preventives, such as vaccines against human papillomaviruses, the main cause of cervical cancer in women.

«Thanks to innovations like the HPV vaccine, we are at a critical juncture in the fight against cervical cancer.

«The HPV vaccine protects young women, men and teens against the human papillomavirus — which can cause cervical, anal, penile and throat cancers — once they become sexually active.

The HPV vaccine protects against the strands of HPV that cause most cases of cervical cancer.

The HPV vaccine protects you against the 9 types responsible for 90 % of cervical and anal cancer cases, along with 90 % of genital warts cases.

All of these vaccines protect against HPV types 16 and 18 — the 2 types that cause 70 % of cervical cancer cases.